Total Return chart Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 10/12/2025			5-day change	1st Jan Change
64.02 ^CNY	+0.95%		+2.76%	+45.17%

12-09	Gan & Lee Pharmaceuticals Gets Clinical Trial Approval For Atopic Dermatitis Drug	MT
11-18	Gan & Lee Pharmaceuticals Europe GmbH Announces Committee for Medicinal Products for Human Use of the European Medicines Agency Recommends the Approval of Insulin Glargine Injection	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.